181 related articles for article (PubMed ID: 12816348)
1. Recent strategies in the search for new anti-influenza therapies.
Wilson JC; von Itzstein M
Curr Drug Targets; 2003 Jul; 4(5):389-408. PubMed ID: 12816348
[TBL] [Abstract][Full Text] [Related]
2. Neuraminidase inhibitors as anti-influenza virus agents.
Kim CU; Chen X; Mendel DB
Antivir Chem Chemother; 1999 Jul; 10(4):141-54. PubMed ID: 10480735
[TBL] [Abstract][Full Text] [Related]
3. Anti-influenza drugs and neuraminidase inhibitors.
Roberts NA
Prog Drug Res; 2001; Spec No():35-77. PubMed ID: 11548210
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of sialidase activity as a therapeutic approach.
Glanz VY; Myasoedova VA; Grechko AV; Orekhov AN
Drug Des Devel Ther; 2018; 12():3431-3437. PubMed ID: 30349196
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in neuraminidase inhibitor development as anti-influenza drugs.
Feng E; Ye D; Li J; Zhang D; Wang J; Zhao F; Hilgenfeld R; Zheng M; Jiang H; Liu H
ChemMedChem; 2012 Sep; 7(9):1527-36. PubMed ID: 22807317
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the structure-based design of neuraminidase inhibitors as antiinfluenza agents.
Shan Y; Ma Y; Wang M; Dong Y
Curr Med Chem; 2012; 19(34):5885-94. PubMed ID: 22963668
[TBL] [Abstract][Full Text] [Related]
7. From neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?
Cheng CK; Tsai CH; Shie JJ; Fang JM
Future Med Chem; 2014 May; 6(7):757-74. PubMed ID: 24941871
[TBL] [Abstract][Full Text] [Related]
8. Recent progress and challenges in the discovery of new neuraminidase inhibitors.
Chamni S; De-Eknamkul W
Expert Opin Ther Pat; 2013 Apr; 23(4):409-23. PubMed ID: 23369206
[TBL] [Abstract][Full Text] [Related]
9. Strategies of development of antiviral agents directed against influenza virus replication.
Hsieh HP; Hsu JT
Curr Pharm Des; 2007; 13(34):3531-42. PubMed ID: 18220789
[TBL] [Abstract][Full Text] [Related]
10. Recent anti-influenza strategies in multivalent sialyloligosaccharides and sialylmimetics approaches.
Sun XL
Curr Med Chem; 2007; 14(21):2304-13. PubMed ID: 17896978
[TBL] [Abstract][Full Text] [Related]
11. Pharmacophore model of influenza neuraminidase inhibitors--a systematic review.
Gong JZ; Liu Y; Xu WF
Pharmazie; 2009 Oct; 64(10):627-32. PubMed ID: 19947162
[TBL] [Abstract][Full Text] [Related]
12. Anti-influenza drugs: the development of sialidase inhibitors.
von Itzstein M; Thomson R
Handb Exp Pharmacol; 2009; (189):111-54. PubMed ID: 19048199
[TBL] [Abstract][Full Text] [Related]
13. The medicinal potential of influenza virus surface proteins: hemagglutinin and neuraminidase.
Xie Y; Gong J; Li M; Fang H; Xu W
Curr Med Chem; 2011; 18(7):1050-66. PubMed ID: 21254972
[TBL] [Abstract][Full Text] [Related]
14. Discovery and development of GS 4104 (oseltamivir): an orally active influenza neuraminidase inhibitor.
Lew W; Chen X; Kim CU
Curr Med Chem; 2000 Jun; 7(6):663-72. PubMed ID: 10702632
[TBL] [Abstract][Full Text] [Related]
15. Anti-influenza virus activity of biflavonoids.
Miki K; Nagai T; Suzuki K; Tsujimura R; Koyama K; Kinoshita K; Furuhata K; Yamada H; Takahashi K
Bioorg Med Chem Lett; 2007 Feb; 17(3):772-5. PubMed ID: 17110111
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyrancarboxamides related to zanamivir: a new series of inhibitors of influenza virus sialidases. 2. Crystallographic and molecular modeling study of complexes of 4-amino-4H-pyran-6-carboxamides and sialidase from influenza virus types A and B.
Taylor NR; Cleasby A; Singh O; Skarzynski T; Wonacott AJ; Smith PW; Sollis SL; Howes PD; Cherry PC; Bethell R; Colman P; Varghese J
J Med Chem; 1998 Mar; 41(6):798-807. PubMed ID: 9526556
[TBL] [Abstract][Full Text] [Related]
17. Influenza hemagglutinin and neuraminidase membrane glycoproteins.
Gamblin SJ; Skehel JJ
J Biol Chem; 2010 Sep; 285(37):28403-9. PubMed ID: 20538598
[TBL] [Abstract][Full Text] [Related]
18. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based covalent neuraminidase inhibitors with broad-spectrum influenza antiviral activity.
Kim JH; Resende R; Wennekes T; Chen HM; Bance N; Buchini S; Watts AG; Pilling P; Streltsov VA; Petric M; Liggins R; Barrett S; McKimm-Breschkin JL; Niikura M; Withers SG
Science; 2013 Apr; 340(6128):71-5. PubMed ID: 23429702
[TBL] [Abstract][Full Text] [Related]
20. Sialobiology of influenza: molecular mechanism of host range variation of influenza viruses.
Suzuki Y
Biol Pharm Bull; 2005 Mar; 28(3):399-408. PubMed ID: 15744059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
